| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 5.21e-08 | 4 | 48 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 5.21e-08 | 4 | 48 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 5.81e-06 | 15 | 48 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 1.69e-05 | 3 | 48 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 8.44e-05 | 6 | 48 | 2 | GO:0140684 | |
| GeneOntologyMolecularFunction | deacetylase activity | 1.21e-04 | 40 | 48 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 3.07e-04 | 11 | 48 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 3.13e-04 | 55 | 48 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 5.06e-04 | 14 | 48 | 2 | GO:0032454 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 7.50e-04 | 74 | 48 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 9.75e-04 | 81 | 48 | 3 | GO:0016811 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 2.06e-03 | 28 | 48 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.52e-03 | 31 | 48 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.68e-03 | 32 | 48 | 2 | GO:0140457 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 5.77e-07 | 8 | 46 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 1.69e-06 | 11 | 46 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 6.91e-06 | 17 | 46 | 3 | GO:0030202 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 1.78e-05 | 70 | 46 | 4 | GO:0030166 | |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 6.45e-05 | 97 | 46 | 4 | GO:0006029 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 6.46e-05 | 35 | 46 | 3 | GO:0015012 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 1.78e-04 | 126 | 46 | 4 | GO:0005976 | |
| GeneOntologyCellularComponent | side of membrane | 1.46e-04 | 875 | 48 | 9 | GO:0098552 | |
| GeneOntologyCellularComponent | Golgi membrane | 2.14e-04 | 721 | 48 | 8 | GO:0000139 | |
| Domain | HSNSD | 5.58e-08 | 4 | 46 | 3 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 5.58e-08 | 4 | 46 | 3 | IPR021930 | |
| Domain | EPHD | 2.08e-05 | 22 | 46 | 3 | PS51805 | |
| Domain | Sulfotransferase_dom | 9.43e-05 | 36 | 46 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 9.43e-05 | 36 | 46 | 3 | PF00685 | |
| Domain | JmjN | 2.64e-04 | 10 | 46 | 2 | SM00545 | |
| Domain | JMJN | 2.64e-04 | 10 | 46 | 2 | PS51183 | |
| Domain | JmjN | 2.64e-04 | 10 | 46 | 2 | PF02375 | |
| Domain | JmjN | 2.64e-04 | 10 | 46 | 2 | IPR003349 | |
| Domain | - | 7.74e-04 | 449 | 46 | 6 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 8.68e-04 | 459 | 46 | 6 | IPR013083 | |
| Domain | PHD | 1.37e-03 | 89 | 46 | 3 | SM00249 | |
| Domain | TUDOR | 1.45e-03 | 23 | 46 | 2 | PS50304 | |
| Domain | Znf_PHD | 1.46e-03 | 91 | 46 | 3 | IPR001965 | |
| Domain | JmjC | 1.58e-03 | 24 | 46 | 2 | PF02373 | |
| Domain | ZF_PHD_2 | 1.65e-03 | 95 | 46 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.70e-03 | 96 | 46 | 3 | PS01359 | |
| Domain | TUDOR | 2.00e-03 | 27 | 46 | 2 | SM00333 | |
| Domain | Tudor | 2.47e-03 | 30 | 46 | 2 | IPR002999 | |
| Domain | JMJC | 2.81e-03 | 32 | 46 | 2 | PS51184 | |
| Domain | JmjC_dom | 2.81e-03 | 32 | 46 | 2 | IPR003347 | |
| Domain | JmjC | 2.98e-03 | 33 | 46 | 2 | SM00558 | |
| Domain | PROTEIN_KINASE_ATP | 5.25e-03 | 459 | 46 | 5 | PS00107 | |
| Domain | Znf_FYVE_PHD | 5.66e-03 | 147 | 46 | 3 | IPR011011 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 2.28e-06 | 11 | 35 | 3 | M47921 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 3.51e-05 | 26 | 35 | 3 | M7330 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 4.90e-05 | 29 | 35 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 6.01e-05 | 31 | 35 | 3 | M685 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 1.40e-04 | 41 | 35 | 3 | M48095 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.19e-04 | 54 | 35 | 3 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.74e-04 | 57 | 35 | 3 | M692 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 22049073 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 12070138 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 11087757 | ||
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 1.37e-07 | 8 | 48 | 3 | 24067353 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 4.04e-07 | 11 | 48 | 3 | 15944372 | |
| Pubmed | 5.38e-07 | 12 | 48 | 3 | 12460940 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 38945286 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23692052 | ||
| Pubmed | Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. | 2.77e-06 | 20 | 48 | 3 | 17107998 | |
| Pubmed | NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. | 3.73e-06 | 22 | 48 | 3 | 19299468 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 27266524 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 9915799 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19696013 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17207460 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17611647 | ||
| Pubmed | The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance. | 5.59e-06 | 3 | 48 | 2 | 31434704 | |
| Pubmed | Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2. | 5.59e-06 | 3 | 48 | 2 | 22357653 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 33462212 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 31014673 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 29688404 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 16056228 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 26120059 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 27257215 | ||
| Pubmed | Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. | 1.86e-05 | 5 | 48 | 2 | 16738407 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 21914792 | ||
| Pubmed | Identification and characterization of JMJD2 family genes in silico. | 2.79e-05 | 6 | 48 | 2 | 15138608 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 10964520 | ||
| Pubmed | Altered heparan sulfate structure in mice with deleted NDST3 gene function. | 3.90e-05 | 7 | 48 | 2 | 18385133 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 21445275 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 29891719 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 19144645 | ||
| Pubmed | Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. | 1.68e-04 | 14 | 48 | 2 | 16603238 | |
| Pubmed | 1.95e-04 | 81 | 48 | 3 | 39217171 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 3.63e-04 | 100 | 48 | 3 | 25807483 | |
| Pubmed | The transcription factor Maz is essential for normal eye development. | 3.85e-04 | 21 | 48 | 2 | 32571845 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 3.85e-04 | 21 | 48 | 2 | 27626377 | |
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 28963472 | ||
| Pubmed | 4.63e-04 | 23 | 48 | 2 | 23725790 | ||
| Pubmed | 5.48e-04 | 25 | 48 | 2 | 24947832 | ||
| Pubmed | 7.98e-04 | 529 | 48 | 5 | 14621295 | ||
| Pubmed | Genome-wide searching of rare genetic variants in WTCCC data. | 9.01e-04 | 32 | 48 | 2 | 20549515 | |
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 9.01e-04 | 32 | 48 | 2 | 37067297 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 9.58e-04 | 33 | 48 | 2 | 26864203 | |
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.14e-03 | 36 | 48 | 2 | 25615642 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 1.16e-03 | 149 | 48 | 3 | 25231870 | |
| Pubmed | 1.20e-03 | 37 | 48 | 2 | 36094016 | ||
| Pubmed | 1.20e-03 | 37 | 48 | 2 | 22432025 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.23e-03 | 1201 | 48 | 7 | 35696571 | |
| Pubmed | Organization, evolution and functions of the human and mouse Ly6/uPAR family genes. | 1.27e-03 | 38 | 48 | 2 | 27098205 | |
| Interaction | NDST4 interactions | 6.60e-07 | 8 | 47 | 3 | int:NDST4 | |
| Cytoband | 4q26 | 9.85e-04 | 44 | 48 | 2 | 4q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q26 | 1.53e-03 | 55 | 48 | 2 | chr4q26 | |
| Cytoband | 17p13.2 | 1.53e-03 | 55 | 48 | 2 | 17p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q34 | 1.88e-03 | 61 | 48 | 2 | chr4q34 | |
| GeneFamily | Sulfotransferases, membrane bound | 5.84e-05 | 37 | 37 | 3 | 763 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.09e-03 | 24 | 37 | 2 | 485 | |
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 2.19e-03 | 34 | 37 | 2 | 1226 | |
| GeneFamily | Tudor domain containing | 2.59e-03 | 37 | 37 | 2 | 780 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 1.92e-05 | 843 | 48 | 9 | M2356 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 3.22e-05 | 498 | 48 | 7 | M1741 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 3.60e-05 | 507 | 48 | 7 | MM1030 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-07 | 164 | 48 | 5 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.25e-06 | 197 | 48 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.30e-06 | 198 | 48 | 5 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-06 | 199 | 48 | 5 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-06 | 199 | 48 | 5 | 3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-05 | 140 | 48 | 4 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 53 | 48 | 3 | 5fa009c9f30c77de6cece40a47da46241f1de54c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 53 | 48 | 3 | 52a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.52e-05 | 172 | 48 | 4 | 1aecc98a3eadabae0f1f328091a9733d916017ec | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 175 | 48 | 4 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 175 | 48 | 4 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.85e-05 | 176 | 48 | 4 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-05 | 178 | 48 | 4 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 180 | 48 | 4 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-05 | 183 | 48 | 4 | c9cb69377883d4579c608ec8b265153fe5290e67 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.48e-05 | 183 | 48 | 4 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-05 | 184 | 48 | 4 | 08bff25390e3484b75c860738396a405141b69fd | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 4.67e-05 | 185 | 48 | 4 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 4.67e-05 | 185 | 48 | 4 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 4.67e-05 | 185 | 48 | 4 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-05 | 185 | 48 | 4 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.67e-05 | 185 | 48 | 4 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.77e-05 | 186 | 48 | 4 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 186 | 48 | 4 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 186 | 48 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-05 | 187 | 48 | 4 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 187 | 48 | 4 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-05 | 187 | 48 | 4 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.87e-05 | 187 | 48 | 4 | 9fdfca5b70f585843ef9d810154674a8e561e765 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.87e-05 | 187 | 48 | 4 | a525753a8a908ee1ef0b8f06e68855e4af27bf86 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.98e-05 | 188 | 48 | 4 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 5.08e-05 | 189 | 48 | 4 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.08e-05 | 189 | 48 | 4 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.08e-05 | 189 | 48 | 4 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.18e-05 | 190 | 48 | 4 | 632b9541371483d25948b6f033863c49f38e3603 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-05 | 190 | 48 | 4 | d8c1998eb02d5105598608d4733b63978ffa3eb2 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.18e-05 | 190 | 48 | 4 | 0523f1039b39a45a23f2f4444e5b47ed581fc4bb | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-05 | 190 | 48 | 4 | b8897c3e0fe8bb7efaf6a3787104d454d81a4c92 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 48 | 4 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.29e-05 | 191 | 48 | 4 | afff6bfae9a2f1e17d2731315e7fe63c4601679f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 48 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 191 | 48 | 4 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.40e-05 | 192 | 48 | 4 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-Treg|COVID-19_Severe / Disease group, lineage and cell class | 5.40e-05 | 192 | 48 | 4 | 3fb4c148dadcf5e79094e55c6bb53ec7bf9d44c8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.40e-05 | 192 | 48 | 4 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 193 | 48 | 4 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 5.51e-05 | 193 | 48 | 4 | bac302e69455aaaf1c18f3272bb213242664d747 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 5.51e-05 | 193 | 48 | 4 | f62acf580ba642929f0f430dc4b3a9b6e828d7b0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.51e-05 | 193 | 48 | 4 | 2a06bb3d6bbe544a26dc42d94a10f60acfd3600b | |
| ToppCell | Control-Lymphoid_T/NK-Treg|Control / Disease group, lineage and cell class | 5.51e-05 | 193 | 48 | 4 | 715f2bbee12a7952cba85d9cd8820411983ce790 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.51e-05 | 193 | 48 | 4 | 498d3a83bce6deff69aea71b18a43688e0a8ed7d | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.51e-05 | 193 | 48 | 4 | b4f8afd871fdf9418b92ff419c8ba9739b6093ca | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 5.51e-05 | 193 | 48 | 4 | 2ffe44edf2b02d11a7c10513692eb697a10f911e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 193 | 48 | 4 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 193 | 48 | 4 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 5.62e-05 | 194 | 48 | 4 | e46963d5f156526342ebc0fb9e767d266e812c42 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.62e-05 | 194 | 48 | 4 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | Healthy/Control-CD4+_Tcm|World / Disease group and Cell class | 5.62e-05 | 194 | 48 | 4 | cbdd1786305108cbeddea07a21120067d78c59a0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.62e-05 | 194 | 48 | 4 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.62e-05 | 194 | 48 | 4 | 2faf49d85d09932c9c20d9f675c8093ad802fae5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.62e-05 | 194 | 48 | 4 | fd3d5ac94de3db7136684c86f8589631ad87e6d8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.62e-05 | 194 | 48 | 4 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-05 | 194 | 48 | 4 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-05 | 194 | 48 | 4 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.62e-05 | 194 | 48 | 4 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 5.62e-05 | 194 | 48 | 4 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 195 | 48 | 4 | f43dacc972dc4df574c4639952d3be9fc4201d33 | |
| ToppCell | tumor_Lung-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 5.73e-05 | 195 | 48 | 4 | dd112ef3f8bd0790719827b6bb120918687afdff | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 195 | 48 | 4 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 195 | 48 | 4 | 8a04f0e92d10a368ccda5f566ae67ef51f1d34a9 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.73e-05 | 195 | 48 | 4 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 5.73e-05 | 195 | 48 | 4 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.73e-05 | 195 | 48 | 4 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.73e-05 | 195 | 48 | 4 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-05 | 196 | 48 | 4 | fe90501010128b72e6711c567cb04b012f1520a4 | |
| ToppCell | Severe-Lymphoid-T-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 5.97e-05 | 197 | 48 | 4 | 00d884ec591f63a345d7fd0a6b368f9da4b4c6ce | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-05 | 197 | 48 | 4 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-05 | 197 | 48 | 4 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-05 | 197 | 48 | 4 | 7c9df6025b9d168bd6d041c6cff1e87e08b11847 | |
| ToppCell | B_cells-Memory_B_cells|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.97e-05 | 197 | 48 | 4 | cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-05 | 197 | 48 | 4 | 7a1a3839b2c965136663241b0d4e96c64cfb656a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-05 | 197 | 48 | 4 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | control-Treg|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.97e-05 | 197 | 48 | 4 | a80674a0b996aa57d52bfff7264c57caf4c31cc6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-05 | 197 | 48 | 4 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.08e-05 | 198 | 48 | 4 | c8c9343c19198b6534f8f07e74405e29b3a164bf | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.08e-05 | 198 | 48 | 4 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class | 6.08e-05 | 198 | 48 | 4 | c53405a8d082fbd10131a6ec88b69fdd835f2925 | |
| ToppCell | 343B-Endothelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.08e-05 | 198 | 48 | 4 | fab32347580c7a81ef1fe4fe7b325d9105a947d9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 198 | 48 | 4 | 5b86dc00acf8ac2ede008f5d79c09996485bf250 | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.08e-05 | 198 | 48 | 4 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 198 | 48 | 4 | 13203249e5743ba2699871c184d141207e550a86 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.08e-05 | 198 | 48 | 4 | 531b0f88c95f813e3914c96749f591e80ca321d0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | severe-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.08e-05 | 198 | 48 | 4 | 4935b40fc848037a06055f30d90bde940b9d5321 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-05 | 198 | 48 | 4 | a5f5c0b42ae43ba48a7e4f06c4ad179b2244d941 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.08e-05 | 198 | 48 | 4 | 93773b1abbf46b39e320d628077bf94958b872a4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 198 | 48 | 4 | 71ee440b1ac566db63d0b415c50a0ad064d14f15 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.08e-05 | 198 | 48 | 4 | 812ffe7369bf83ae5071970934c8831611db9557 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-05 | 198 | 48 | 4 | bb99db3e04d547248ea66953c2f8dd55c530461c | |
| Computational | Neighborhood of BMPR2 | 4.62e-04 | 53 | 31 | 3 | MORF_BMPR2 | |
| Computational | Neighborhood of EPHA7 | 6.42e-04 | 139 | 31 | 4 | MORF_EPHA7 | |
| Computational | Genes in the cancer module 119. | 7.15e-04 | 143 | 31 | 4 | MODULE_119 | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 3.53e-06 | 197 | 48 | 6 | 2116_DN | |
| Disease | quinate measurement | 1.70e-06 | 15 | 47 | 3 | EFO_0021167 | |
| Disease | intellectual disability (implicated_via_orthology) | 6.32e-06 | 75 | 47 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 1.08e-05 | 27 | 47 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | sex interaction measurement, Crohn's disease | 2.83e-05 | 37 | 47 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | Pulmonary Hypertension | 3.59e-05 | 40 | 47 | 3 | C0020542 | |
| Disease | Obesity, Morbid | 5.19e-05 | 7 | 47 | 2 | C0028756 | |
| Disease | Papillary Renal Cell Carcinoma | 5.21e-05 | 128 | 47 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.21e-05 | 128 | 47 | 4 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.21e-05 | 128 | 47 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.21e-05 | 128 | 47 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.21e-05 | 128 | 47 | 4 | C1266044 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 9.17e-05 | 148 | 47 | 4 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.02e-04 | 152 | 47 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 1.11e-04 | 10 | 47 | 2 | DOID:986 (is_marker_for) | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 1.41e-04 | 63 | 47 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | autoimmune disease | 1.67e-04 | 173 | 47 | 4 | EFO_0005140 | |
| Disease | atrial fibrillation | 3.04e-04 | 371 | 47 | 5 | EFO_0000275 | |
| Disease | sphingomyelin 14:0 measurement | 3.33e-04 | 17 | 47 | 2 | EFO_0010390 | |
| Disease | posterior cingulate cortex volume measurement | 3.33e-04 | 17 | 47 | 2 | EFO_0010324 | |
| Disease | age at menarche | 3.46e-04 | 594 | 47 | 6 | EFO_0004703 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 3.74e-04 | 18 | 47 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | alpha-tocopherol measurement | 4.63e-04 | 20 | 47 | 2 | EFO_0007898 | |
| Disease | Immunologic Deficiency Syndromes | 6.15e-04 | 23 | 47 | 2 | C0021051 | |
| Disease | stomach carcinoma (is_marker_for) | 6.70e-04 | 24 | 47 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Autosomal Dominant Parkinsonism | 9.14e-04 | 28 | 47 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 9.14e-04 | 28 | 47 | 2 | C0752097 | |
| Disease | Parkinsonism, Experimental | 9.14e-04 | 28 | 47 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 9.14e-04 | 28 | 47 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 9.14e-04 | 28 | 47 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 9.14e-04 | 28 | 47 | 2 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 9.14e-04 | 28 | 47 | 2 | C1868675 | |
| Disease | Parkinsonism, Juvenile | 1.05e-03 | 30 | 47 | 2 | C0752105 | |
| Disease | Parkinsonian Disorders | 1.05e-03 | 30 | 47 | 2 | C0242422 | |
| Disease | obsolete_red blood cell distribution width | 1.19e-03 | 1347 | 47 | 8 | EFO_0005192 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKVSWYCILGCKAEG | 931 | Q96N23 | |
| FLWGVIKQGYRCKDC | 561 | O95267 | |
| WKLTCYICKQKGLGA | 321 | Q9ULD4 | |
| CIKTLRYCAGWADKI | 126 | P00352 | |
| CLITKAGLQVYNKCW | 51 | P13987 | |
| KADIWALGCLLYKLC | 246 | Q9NSY1 | |
| CKYGEVCRELWCLSK | 501 | Q9UKP5 | |
| GTYGLDSVKKKCLEW | 221 | Q96IK5 | |
| GFWCQLLEEGKTKCL | 806 | O95803 | |
| MGLKCNTCIYTEGWK | 21 | P0C8F1 | |
| LKYLWTVCCHCGGKT | 111 | Q12791 | |
| IWALGCVLYELCTLK | 186 | Q96PY6 | |
| WLYITCRKVCKGAEK | 321 | O14524 | |
| CFWKTEVLVKACPGG | 146 | P55259 | |
| FWCQLLEGGKTKCLG | 816 | P52848 | |
| WIEYGKQAVLCSCRK | 296 | O75164 | |
| VRWIDYGKVAKLCTC | 296 | Q9H3R0 | |
| CGEGETLLKKWALYS | 1801 | Q5S007 | |
| KVDGKLLCWLCTLSY | 121 | Q5HYJ3 | |
| CWLKGDLKLFICYVE | 131 | P48357 | |
| LWLCLYAKLGELCVD | 1021 | Q7Z3U7 | |
| FWCQLLEGGKTKCLG | 806 | Q9H3R1 | |
| WLVPIGKCICKAGYQ | 256 | Q15375 | |
| LGCILICWLTKKKYS | 156 | Q9Y6W8 | |
| YIWVKRSLNCVLKCG | 191 | Q9ULV1 | |
| YKIWQCGGKLLFVPC | 421 | Q86SF2 | |
| CYGLWEKSKGDINLV | 66 | Q13873 | |
| CIWKLLYAGADVQKG | 216 | Q8WWX0 | |
| AVGLECGKICLYTWK | 741 | Q6IA86 | |
| CGKICLYTWKKTDQV | 746 | Q6IA86 | |
| IIYDCEGLGLKHLWK | 151 | O76054 | |
| EVYVGDKTKWILGVC | 296 | Q96PL5 | |
| LVRKTWKCGYVECSA | 146 | Q96S79 | |
| RLEWHIKGKYTCLGC | 446 | Q6YHU6 | |
| SVGLGLILYCVCKWQ | 31 | Q6UWF3 | |
| GIGLNEKFLYCCEKW | 5591 | Q8WXH0 | |
| LCVCEEGGNKLWYKK | 66 | Q8TBP6 | |
| WGYVSALVKGCRCLE | 186 | Q86YW0 | |
| FCYLCVKGASWLGKR | 56 | Q9NTX7 | |
| LLEGTCYNGKLIWKV | 396 | O00463 | |
| ILAYCQKEGWCKLAF | 111 | O95406 | |
| CDTYIVLAWISKIKG | 36 | Q9BVW6 | |
| KLLLFCQEDGKVICW | 101 | Q9C035 | |
| LKCPVCSFVYGTKWE | 1041 | Q9P243 | |
| CLFCVWKFVRTGKKG | 511 | P06133 | |
| ALLWSIETGKCLVKY | 181 | Q9Y2I8 | |
| KECGKAYGWCSELIR | 391 | Q9UNY5 | |
| ILKPGCKEYFWLLCK | 1726 | Q70CQ2 | |
| VGERWYKPGCKELCV | 1491 | Q9Y493 |